Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFB | P00751 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 11/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 11/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 11/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11122793 | 0.89 | ADRA2A (0.46) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL4266232 | 0.79 | HPGD (0.55) | CFBTAAR1HTR3A | |
| SCHEMBL7629026 | 0.78 | ADRA2A (0.50) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL6690990 | 0.77 | PTGIR (0.43) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL9558516 | 0.77 | TAAR1 (0.45) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL7047648 | 0.74 | TAAR1 (0.56) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL9559073 | 0.73 | ADRA2A (0.47) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL29920861 | 0.73 | ADRA2A (0.59) | ADRA2AADRA2BADRA2CPOLBHSD17B10 | |
| SCHEMBL19565793 | 0.72 | TAAR1 (0.47) | CFBADRA2AADRA2BADRA2CTAAR1 | |
| SCHEMBL2754359 | 0.72 | HSD17B10 (0.51) | CFBADRA2AADRA2BADRA2CTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322231-B | Oxazolinyl N, N-bidentate iron complex, preparation method and application | 大连理工大学 | 2024-01-26 | — | — | CN | claimed |
| CN-115322231-A | Oxazoline-based N, N-bidentate iron complex, preparation method and application | 大连理工大学 | 2022-11-11 | — | — | CN | claimed |
| CN-108623731-B | Aniline-oxazoline rare earth metal catalyst, preparation method and application | 大连理工大学 | 2020-06-12 | — | — | CN | claimed |
| CN-108623731-A | - oxazoline rare-earth metal catalyst of aniline, preparation method and application | 大连理工大学 | 2018-10-09 | — | — | CN | claimed |
| EP-2035436-B1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA SA (BE) | 2011-05-25 | — | — | EP | claimed |
| CN-115322231-B | Oxazolinyl N, N-bidentate iron complex, preparation method and application | 大连理工大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-115322231-A | Oxazoline-based N, N-bidentate iron complex, preparation method and application | 大连理工大学 | 2022-11-11 | — | — | CN | disclosed |
| CN-115322231-A | Oxazoline-based N, N-bidentate iron complex, preparation method and application | 大连理工大学 | 2022-11-11 | — | — | CN | disclosed |
| CN-108586372-B | Synthesis method of 2-aryl oxazoline amide compound | 商丘师范学院 | 2021-06-08 | — | — | CN | disclosed |
| CN-108623731-B | Aniline-oxazoline rare earth metal catalyst, preparation method and application | 大连理工大学 | 2020-06-12 | — | — | CN | disclosed |
| CN-108623731-B | Aniline-oxazoline rare earth metal catalyst, preparation method and application | 大连理工大学 | 2020-06-12 | — | — | CN | disclosed |
| CN-108623731-B | Aniline-oxazoline rare earth metal catalyst, preparation method and application | 大连理工大学 | 2020-06-12 | — | — | CN | disclosed |
| US-5338828-A | Mesogenic cyclic imino ether-containing compositions and polymerization products thereof | THE DOW CHEMICAL COMPANY (US) | 1994-08-16 | — | — | US | disclosed |
| US-5281675-A | Liquid crystal polymers | THE DOW CHEMICAL COMPANY (US) | 1994-01-25 | — | — | US | disclosed |
| EP-0030350-B1 | METHOD FOR REDUCING THE TERMINAL CARBOXYL GROUP CONTENT OF A SATURATED POLYESTER, A SATURATED POLYESTER HAVING A REDUCED TERMINAL CARBOXYL GROUP CONTENT, AND A MOLDED ARTICLE COMPOSED OF SUCH A SATURATED POLYESTER | TEIJIN LIMITED (JP) | 1984-10-10 | — | — | EP | disclosed |
| US-4351936-A | COMPRISING ENDCAPPING WITH AN OXAZOLINE OR OXAZINE | TEIJIN LIMITED (JP) | 1982-09-28 | — | — | US | disclosed |
| EP-0030350-A1 | Method for reducing the terminal carboxyl group content of a saturated polyester, a saturated polyester having a reduced terminal carboxyl group content, and a molded article composed of such a saturated polyester | TEIJIN LIMITED (JP) | 1981-06-17 | — | — | EP | disclosed |
| US-4176120-A | HYPOTENSIVE AGENTS | SCHERING CORPORATION (US) | 1979-11-27 | — | — | US | disclosed |
| US-4159335-A | HYPOTENSIVE AGENT | SCHERING CORPORATION (US) | 1979-06-26 | — | — | US | disclosed |
| US-4081547-A | PARA-POLYFLUOROISOPROPYL-ANILINO-2-OXAZOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATING HYPERTENSION | SCHERING CORPORATION (US) | 1978-03-28 | — | — | US | disclosed |